positive regulation of transforming growth factor beta2 production / positive regulation of cardiac ventricle development / fibrous ring of heart morphogenesis / atrioventricular node cell development / anti-Mullerian hormone receptor signaling pathway / dorsal aorta morphogenesis / tricuspid valve morphogenesis / cardiac right ventricle morphogenesis / regulation of cardiac muscle cell proliferation / BMP binding ...positive regulation of transforming growth factor beta2 production / positive regulation of cardiac ventricle development / fibrous ring of heart morphogenesis / atrioventricular node cell development / anti-Mullerian hormone receptor signaling pathway / dorsal aorta morphogenesis / tricuspid valve morphogenesis / cardiac right ventricle morphogenesis / regulation of cardiac muscle cell proliferation / BMP binding / pharyngeal arch artery morphogenesis / atrioventricular valve development / mitral valve morphogenesis / BMP receptor activity / ventricular compact myocardium morphogenesis / cardiac conduction system development / negative regulation of smooth muscle cell migration / transforming growth factor beta receptor activity, type I / endocardial cushion formation / receptor protein serine/threonine kinase / cellular response to BMP stimulus / transmembrane receptor protein serine/threonine kinase activity / Signaling by BMP / ventricular trabecula myocardium morphogenesis / dorsal/ventral pattern formation / outflow tract septum morphogenesis / endocardial cushion morphogenesis / chondrocyte differentiation / positive regulation of dendrite development / embryonic organ development / ventricular septum morphogenesis / positive regulation of bone mineralization / SMAD binding / outflow tract morphogenesis / positive regulation of cardiac muscle cell proliferation / positive regulation of osteoblast differentiation / positive regulation of SMAD protein signal transduction / BMP signaling pathway / transforming growth factor beta receptor signaling pathway / positive regulation of vascular associated smooth muscle cell proliferation / stem cell differentiation / HFE-transferrin receptor complex / cellular response to growth factor stimulus / positive regulation of miRNA transcription / osteoblast differentiation / angiogenesis / cell differentiation / signaling receptor complex / immune response / negative regulation of gene expression / external side of plasma membrane / protein serine/threonine kinase activity / neuronal cell body / positive regulation of gene expression / dendrite / positive regulation of transcription by RNA polymerase II / protein homodimerization activity / ATP binding / membrane / metal ion binding / plasma membrane Similarity search - Function
GS domain / Transforming growth factor beta type I GS-motif / GS domain profile. / GS motif / Activin types I and II receptor domain / Activin types I and II receptor domain / CD59 / CD59 / Ser/Thr protein kinase, TGFB receptor / Snake toxin-like superfamily ...GS domain / Transforming growth factor beta type I GS-motif / GS domain profile. / GS motif / Activin types I and II receptor domain / Activin types I and II receptor domain / CD59 / CD59 / Ser/Thr protein kinase, TGFB receptor / Snake toxin-like superfamily / Ribbon / Protein tyrosine and serine/threonine kinase / Serine-threonine/tyrosine-protein kinase, catalytic domain / Serine/threonine-protein kinase, active site / Serine/Threonine protein kinases active-site signature. / Serine/Threonine protein kinases, catalytic domain / Protein kinase, ATP binding site / Protein kinases ATP-binding region signature. / Protein kinase domain profile. / Protein kinase domain / Protein kinase-like domain superfamily / Mainly Beta Similarity search - Domain/homology
Mass: 11278.693 Da / Num. of mol.: 1 / Fragment: Extracellular domain (UNP residues 51-152) / Mutation: A28G Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: BMPR1A, ACVRLK3, ALK3 / Production host: Escherichia coli (E. coli) / Strain (production host): BL21(DE3) References: UniProt: P36894, receptor protein serine/threonine kinase
Has protein modification
Y
-
Experimental details
-
Experiment
Experiment
Method: SOLUTION NMR
NMR experiment
Conditions-ID
Experiment-ID
Solution-ID
Type
1
1
2
2D 1H-15N HSQC
1
2
2
2D 1H-13C HSQC
1
3
2
3D HNCO
1
4
2
3D HNCA
1
5
2
3DCBCA(CO)NH
1
6
2
3DHBHA(CO)NH
1
7
2
3D HN(CA)CB
1
8
2
3DC(CO)NH
1
9
2
3D (H)CCH-TOCSY
1
10
1
3D HNHA
1
11
2
2D 1H-1H NOESY
1
12
2
3D 1H-15N NOESY
1
13
2
3D 1H-13C NOESY
1
14
1
3D HNHB
1
15
2
3D (H)CCH-COSY
1
16
2
3D 1H-15N-15N NOESY
1
17
2
3D 1H-15N-13C NIOESY
1
18
2
3D (H)CCH-TOCSY
1
19
2
3DHN(CA)HA
1
20
2
3DHN(CA)CO
-
Sample preparation
Details
Solution-ID
Contents
Solvent system
1
1.1 mM [U-99% 15N] Bone Morphogenetic Protein Receptor Type IA, 10 mM potassium phosphate, 0.2 w/v sodium azide, 95% H2O/5% D2O
95% H2O/5% D2O
2
0.5 mM [U-94% 13C; U-98% 15N] Bone Morphogenetic Protein Receptor Type IA, 10 mM potassium phosphate, 0.2 w/v sodium azide, 95% H2O/5% D2O
95% H2O/5% D2O
Sample
Conc. (mg/ml)
Component
Isotopic labeling
Solution-ID
1.1mM
BoneMorphogeneticProteinReceptorTypeIA
[U-99% 15N]
1
95v/v
H2O
1
5v/v
D2O
1
10mM
potassiumphosphate
1
0.2w/v
sodiumazide
1
0.5mM
BoneMorphogeneticProteinReceptorTypeIA
[U-94% 13C; U-98% 15N]
2
95v/v
H2O
2
5v/v
D2O
2
10mM
potassiumphosphate
2
0.2w/v
sodiumazide
2
Sample conditions
pH: 6.3 / Pressure: ambient / Temperature: 298 K
-
NMR measurement
NMR spectrometer
Type
Manufacturer
Model
Field strength (MHz)
Spectrometer-ID
Bruker Avance
Bruker
AVANCE
900
1
Bruker DMX
Bruker
DMX
750
2
Bruker DMX
Bruker
DMX
600
3
Bruker DMX
Bruker
DMX
600
4
-
Processing
NMR software
Name
Version
Developer
Classification
X-PLOR NIH
2.9.4a
Schwieters, Kuszewski, TjandraandClore
structuresolution
TopSpin
1.3
BrukerBiospin
processing
TopSpin
1.3
BrukerBiospin
collection
Sparky
Goddard
dataanalysis
TALOS
Cornilescu, DelaglioandBax
dataanalysis
ProcheckNMR
LaskowskiandMacArthur
geometryoptimization
AQUA
Rullmann, DoreleijersandKaptein
geometryoptimization
WHAT IF
Vriend
geometryoptimization
X-PLOR NIH
2.9.4a
Schwieters, Kuszewski, TjandraandClore
refinement
Refinement
Method: simulated annealing / Software ordinal: 1 / Details: standard protocols were used
NMR constraints
NOE constraints total: 699 / NOE intraresidue total count: 167 / NOE long range total count: 182 / NOE medium range total count: 57 / NOE sequential total count: 249
NMR representative
Selection criteria: minimized average structure
NMR ensemble
Conformer selection criteria: structures with the lowest energy Conformers calculated total number: 50 / Conformers submitted total number: 21
NMR ensemble rms
Distance rms dev: 0.022 Å / Distance rms dev error: 0.002 Å
+
About Yorodumi
-
News
-
Feb 9, 2022. New format data for meta-information of EMDB entries
New format data for meta-information of EMDB entries
Version 3 of the EMDB header file is now the official format.
The previous official version 1.9 will be removed from the archive.
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator
Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.
Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi